Cargando…

Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases

BACKGROUND: The incidence of pediatric inflammatory bowel disease (PIBD) has been steadily increasing globally. Delayed diagnosis of PIBD increases the risk of complications and contributes to growth retardation. To improve long-term outcomes, there is a pressing need to identify novel markers for e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xixi, Gao, Yuanqi, Xie, Jinfang, Hua, Huiying, Pan, Chun, Huang, Jiebin, Jing, Mengxia, Chen, Xuehua, Xu, Chundi, Gao, Yujing, Li, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022188/
https://www.ncbi.nlm.nih.gov/pubmed/36932401
http://dx.doi.org/10.1186/s12967-023-04038-1
_version_ 1784908674977759232
author Chen, Xixi
Gao, Yuanqi
Xie, Jinfang
Hua, Huiying
Pan, Chun
Huang, Jiebin
Jing, Mengxia
Chen, Xuehua
Xu, Chundi
Gao, Yujing
Li, Pu
author_facet Chen, Xixi
Gao, Yuanqi
Xie, Jinfang
Hua, Huiying
Pan, Chun
Huang, Jiebin
Jing, Mengxia
Chen, Xuehua
Xu, Chundi
Gao, Yujing
Li, Pu
author_sort Chen, Xixi
collection PubMed
description BACKGROUND: The incidence of pediatric inflammatory bowel disease (PIBD) has been steadily increasing globally. Delayed diagnosis of PIBD increases the risk of complications and contributes to growth retardation. To improve long-term outcomes, there is a pressing need to identify novel markers for early diagnosis of PIBD. METHODS: The candidate biomarkers for PIBD were identified from the GSE117993 dataset by two machine learning algorithms, namely LASSO and mSVM-RFE, and externally validated in the GSE126124 dataset and our PIBD cohort. The role of ficolin-1 (FCN1) in PIBD and its association with macrophage infiltration was investigated using the CIBERSORT method and enrichment analysis of the single-cell dataset GSE121380, and further validated using immunoblotting, qRT-PCR, and immunostaining in colon biopsies from PIBD patients, a juvenile murine DSS-induced colitis model, and THP-1-derived macrophages. RESULTS: FCN1 showed great diagnostic performance for PIBD in an independent clinical cohort with the AUC of 0.986. FCN1 expression was upregulated in both colorectal biopsies and blood samples from PIBD patients. Functionally, FCN1 was associated with immune-related processes in the colonic mucosa of PIBD patients, and correlated with increased proinflammatory M1 macrophage infiltration. Furthermore, single-cell transcriptome analysis and immunostaining revealed that FCN1 was almost exclusively expressed in macrophages infiltrating the colonic mucosa of PIBD patients, and these FCN1(+) macrophages were related to hyper-inflammation. Notably, proinflammatory M1 macrophages derived from THP-1 expressed high levels of FCN1 and IL-1β, and FCN1 overexpression in THP-1-derived macrophages strongly promoted LPS-induced activation of the proinflammatory cytokine IL-1β via the NLRP3-caspase-1 axis. CONCLUSIONS: FCN1 is a novel and promising diagnostic biomarker for PIBD. FCN1(+) macrophages enriched in the colonic mucosa of PIBD exhibit proinflammatory phenotypes, and FCN1 promotes IL-1β maturation in macrophages via the NLRP3-caspase-1 axis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04038-1.
format Online
Article
Text
id pubmed-10022188
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100221882023-03-18 Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases Chen, Xixi Gao, Yuanqi Xie, Jinfang Hua, Huiying Pan, Chun Huang, Jiebin Jing, Mengxia Chen, Xuehua Xu, Chundi Gao, Yujing Li, Pu J Transl Med Research BACKGROUND: The incidence of pediatric inflammatory bowel disease (PIBD) has been steadily increasing globally. Delayed diagnosis of PIBD increases the risk of complications and contributes to growth retardation. To improve long-term outcomes, there is a pressing need to identify novel markers for early diagnosis of PIBD. METHODS: The candidate biomarkers for PIBD were identified from the GSE117993 dataset by two machine learning algorithms, namely LASSO and mSVM-RFE, and externally validated in the GSE126124 dataset and our PIBD cohort. The role of ficolin-1 (FCN1) in PIBD and its association with macrophage infiltration was investigated using the CIBERSORT method and enrichment analysis of the single-cell dataset GSE121380, and further validated using immunoblotting, qRT-PCR, and immunostaining in colon biopsies from PIBD patients, a juvenile murine DSS-induced colitis model, and THP-1-derived macrophages. RESULTS: FCN1 showed great diagnostic performance for PIBD in an independent clinical cohort with the AUC of 0.986. FCN1 expression was upregulated in both colorectal biopsies and blood samples from PIBD patients. Functionally, FCN1 was associated with immune-related processes in the colonic mucosa of PIBD patients, and correlated with increased proinflammatory M1 macrophage infiltration. Furthermore, single-cell transcriptome analysis and immunostaining revealed that FCN1 was almost exclusively expressed in macrophages infiltrating the colonic mucosa of PIBD patients, and these FCN1(+) macrophages were related to hyper-inflammation. Notably, proinflammatory M1 macrophages derived from THP-1 expressed high levels of FCN1 and IL-1β, and FCN1 overexpression in THP-1-derived macrophages strongly promoted LPS-induced activation of the proinflammatory cytokine IL-1β via the NLRP3-caspase-1 axis. CONCLUSIONS: FCN1 is a novel and promising diagnostic biomarker for PIBD. FCN1(+) macrophages enriched in the colonic mucosa of PIBD exhibit proinflammatory phenotypes, and FCN1 promotes IL-1β maturation in macrophages via the NLRP3-caspase-1 axis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04038-1. BioMed Central 2023-03-17 /pmc/articles/PMC10022188/ /pubmed/36932401 http://dx.doi.org/10.1186/s12967-023-04038-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Xixi
Gao, Yuanqi
Xie, Jinfang
Hua, Huiying
Pan, Chun
Huang, Jiebin
Jing, Mengxia
Chen, Xuehua
Xu, Chundi
Gao, Yujing
Li, Pu
Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
title Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
title_full Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
title_fullStr Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
title_full_unstemmed Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
title_short Identification of FCN1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
title_sort identification of fcn1 as a novel macrophage infiltration-associated biomarker for diagnosis of pediatric inflammatory bowel diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022188/
https://www.ncbi.nlm.nih.gov/pubmed/36932401
http://dx.doi.org/10.1186/s12967-023-04038-1
work_keys_str_mv AT chenxixi identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT gaoyuanqi identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT xiejinfang identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT huahuiying identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT panchun identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT huangjiebin identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT jingmengxia identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT chenxuehua identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT xuchundi identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT gaoyujing identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases
AT lipu identificationoffcn1asanovelmacrophageinfiltrationassociatedbiomarkerfordiagnosisofpediatricinflammatoryboweldiseases